Article
Measurement of ras p21 in the urine of patients with urological tumours.
In vivo (Athens, Greece) - 1 Jan 2000
Scobbie A E, Anderson J B, Horwich A
Abstract excerpt
We have measured the product of the ras oncogene, ras p21, in random un-timed urine samples using an immunoblotting method which relies upon enhanced chemiluminescence for visualisation of the nitrocellulose filter. Urine samples were analysed from groups of patients with prostate (n = 10) or bladder (n = 25) cancer and a control group (n = 30) with no apparent urological disease. The mean concentration of...
Topics
- Humans
- Male
- Mutation
- Prostatic Neoplasms
- Proto-Oncogene Proteins p21(ras)
- Urinary Bladder Neoplasms